Tabernanthe iboga Facts
Hallucinogen;
Description
''Iboga (Tabernanthe iboga'' Baillon, Apocynaceae) — eboka — is a West and Central African rainforest shrub whose root bark is consumed as a powerful psychoactive preparation. Its dominant alkaloid, ibogaine, acts on multiple brain systems simultaneously — including glutamate, opioid, nicotinic, and serotonin pathways.[1] This broad multi-system action produces prolonged visionary and dissociative states unlike any other known plant.
Subjective effects include vivid autobiographical visions, contact with perceived entities, intense body sensitivity, profound dissociation, and severe loss of coordination.[2] The experience is predominantly internal and dream-like, lasting 12–24 hours in the acute phase with residual effects persisting up to 72 hours.
Ibogaine does not produce physical dependence or compulsive redosing,[3] but the primary acute risk is cardiac — ibogaine slows heart repolarization in a way that can trigger fatal arrhythmias, particularly without continuous cardiac monitoring.[4] Co-administration with other heart-affecting drugs or certain antidepressants substantially amplifies this risk.
Dose and duration
No dose or duration recorded for any route.
Body and dependence
- Acute toxicity
- High
- Chronic toxicity
- Moderate
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- None
- Fully resets after
- Not recorded
Effectslikely at a common dose
- Perception
- Dreaming enhancement;
Holotropic state; Sleep-transition hallucinations; Spatial disorientation; Vestibular distortion; +10 possible, including Visual haze / noise - Body
- Dizziness;
Insomnia; Motor control impairment; Nausea; Physical fatigue; Wakefulness; +20 possible, including Nystagmus (eye wobbles), Trembling, Vomiting - Thinking
- Cognitive impairment;
Introspection enhancement; Memory replays; +14 possible, including Confusion, Decision impairment, Information processing suppression - Feeling
- none likely · 9 possible, including Anxiety, Dysphoria, Emotional lability
- Self
- none likely · 8 possible, including Social disconnection, Communication suppression, Depersonalization
- Time
- none likely · 2 possible, including Temporal disorientation
- Transpersonal
- none likely · 1 possible
- Awareness
- Personal insight
Who shouldn't take it
Combinations60 recorded
Seek help immediately if
No emergency profile is recorded for this substance. Not recorded never means no risk.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Hwu C et al., Sames D (2026) Deciphering Ibogaine's Matrix Pharmacology: Multiple Transporter Modulation at Serotonin Synapses — Journal of the American Chemical Society doi:10.1021/jacs.5c06325
- [2]^González Espejito F et al., Bouso JC (2025) The Ibogaine Experience Scale (IES): Development and psychometric properties of a multidimensional measure of ibogaine's subjective effects — PloS one doi:10.1371/journal.pone.0333296
- [3]^Belgers M, Leenaars M, Homberg JR, Ritskes-Hoitinga M, Schellekens AF, Hooijmans CR (2016) Ibogaine and addiction in the animal model, a systematic review and meta-analysis — Translational psychiatry doi:10.1038/tp.2016.71
- [4]^Koenig X, Hilber K (2015) The anti-addiction drug ibogaine and the heart: a delicate relation — Molecules doi:10.3390/molecules20022208